Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
TRxADE HEALTH, Inc. MEDS
$0.39
-$0.01 (-3.29%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3742044.00000000
-
week52high
1.90
-
week52low
0.25
-
Revenue
11448265
-
P/E TTM
-1
-
Beta
1.28096800
-
EPS
-0.44000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| EF Hutton | Buy | 09 дек 2021 г. | |
| National Securities | Buy | 03 дек 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| PETERSON MICHAEL L | A | 135802 | 135802 | 16 янв 2023 г. |
| PETERSON MICHAEL L | A | 118940 | 100000 | 16 янв 2023 г. |
| Newell A. Jeffrey | A | 79062 | 79062 | 30 дек 2022 г. |
| Patel Prashant | A | 1261120 | 8620 | 01 сент 2022 г. |
| Fell Donald G. | A | 75664 | 54525 | 01 сент 2022 г. |
| Huffman Janet | A | 21551 | 21551 | 01 сент 2022 г. |
| AJJARAPU SURENDRA K | A | 1164240 | 51724 | 01 сент 2022 г. |
| POPE CHARLES L | A | 65437 | 54525 | 01 сент 2022 г. |
| Fell Donald G. | A | 21139 | 1500 | 25 авг 2022 г. |
| AJJARAPU SURENDRA K | A | 222500 | 10000 | 20 мая 2022 г. |
Новостная лента
All You Need to Know About TRxADE (MEDS) Rating Upgrade to Strong Buy
Zacks Investment Research
12 янв 2023 г. в 13:33
TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
All You Need to Know About TRxADE (MEDS) Rating Upgrade to Buy
Zacks Investment Research
17 ноя 2022 г. в 13:32
TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
7 Meme Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole
InvestorPlace
09 ноя 2022 г. в 11:43
Meme stocks represented one of the most remarkable developments in the equities space during much of the new normal. However, by 2022, this sector received a very rude awakening.
TRxADE Health, Inc. (MEDS) Q3 2022 Earnings Call Transcript
Seeking Alpha
08 ноя 2022 г. в 00:42
TRxADE Health, Inc. (NASDAQ:MEDS ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Janet Huffman - CFO & Principal Accounting Officer Surendra Ajjarapu - Founder, Chairman, CEO, Treasurer & Secretary Conference Call Participants Allen Klee - Maxim Group Howard Halpern - Taglich Brothers Operator Good afternoon, and welcome to TRxADE Conference Call. [Operator Instructions].
TRxADE (MEDS) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research
07 ноя 2022 г. в 20:19
TRxADE (MEDS) delivered earnings and revenue surprises of 50% and 27.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?